0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Arthritis Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Arthritis Monoclonal Antibodies Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$2,349USDGBP
Migraine Treatment Market Report 2025 - Product Thumbnail Image

Migraine Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Epidural Abscess Treatment Market Report 2025 - Product Thumbnail Image

Epidural Abscess Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$7,950USDGBP
Diabetic Neuropathy Drugs Market 2021-2025 - Product Thumbnail Image

Diabetic Neuropathy Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
EUR$2,500USDGBP
From
EUR$4,750USDGBP
Allergy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Allergy Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
EUR$4,949USDGBP
From
EUR$4,949USDGBP
Loading Indicator